Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from leguminosae
Reexamination Certificate
2008-03-04
2008-03-04
Flood, Michele (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from leguminosae
C424S776000, C514S556000, C514S561000
Reexamination Certificate
active
10434444
ABSTRACT:
A composition of bio-active compounds and methods for facilitating and supporting the metabolism and transport of glucose and carbohydrates into muscle cells. Preferably, the composition of bio-active compounds include 4-hydroxyisoleucine and one or more amino acids selected from the group consisting of arginine, aspartate, threonine, serine, glutamate, proline, glycine, alanine, cysteine, valine, methionine, isoleucine, leucine, tryptophan, phenylalanine, ornithine, lysine, histidine and gamma-amino butyrate. In one presently preferred embodiment of the present invention, the bio-active compounds are extracted from fenugreek seeds. A method for extracting a composition of bio-active compounds from fenugreek seeds is also disclosed, wherein the method comprises the steps of: (1) providing a plurality of fenugreek seeds; (2) preparing the fenugreek seeds; and (3) extracting a composition of bio-active compounds from the fenugreek seeds, wherein the bio-active compounds comprise 4-hydroxyisoleucine and one or more amino acids selected from the group consisting of arginine, aspartate, threonine, serine, glutamate, proline, glycine, alanine, cysteine, valine, methionine, isoleucine, leucine, tryptophan, phenylalanine, ornithine, lysine, histidine and gamma-amino butyrate. The composition of bio-active compounds and methods for extraction of same preferably include between about 10% and 70% of 4-hydroxyisoleucine and between about 20% and 40% of the amino acids.
REFERENCES:
patent: 5449823 (1995-09-01), Lerch
patent: 5470879 (1995-11-01), Sauvaire et al.
patent: 5658571 (1997-08-01), Gopalan et al.
patent: 5997877 (1999-12-01), Chang
patent: 6413546 (2002-07-01), He et al.
patent: 587476 (1998-03-01), None
patent: WO 97/32577 (1997-09-01), None
patent: WO 99/25197 (1999-05-01), None
patent: WO 01/15689 (2001-03-01), None
Sauvaire et al., Phytochemistry (1984), 23: 479-486. Changes in growth, proteins and free amino acids of developing seeds and pods of fenugreek.
URL: http://www.tsiinc.com/products/brand/phtml?brand—id =19 (Accessed May 21, 2003) Promilin product information.
URL: http://www.airgreen.co.jp/fenugreek/index—e.html (Accessed Jan. 16, 2003) Fenugreek.
Garti N Et al., “Fenugreek Gum. the magic fiber for an improved glucose response and cholesterol reduction,” NutraCos May/Jun. 2002; 1 (3): 5-10.
Belongie L, “Syndrome X Analyzed,” HSR Health Supplement Retailer, Apr. 2002.
URL: http://www.sabinsa.com/products/fenusterl.htm (Accessed Apr. 4, 2002).
URL: http://www.kbcincusa.com/BrandNameProducts/Sterofen/STEROFENSpec.htm (Accessed Apr. 2, 2002) Sterofen.
URL: http://www.finsupplements.com/search/Details.asp?RefSite=altdia&ProductID=6 (Accessed Mar. 26, 2002) NatureS Way Blood Sugar with Gymnema.
URL: http://www.chromadex.com/Phytosearch/Fenugreek.htm (Accessed Jan. 17, 2002) Fenugreek.
Billaud et al., “Fenugreek: composition, nutritional value and physiological properties,” Sciences des Aliments 2001; 21(1):3-26. [Abstract].
Zupancic et al., “The impact of fertilization on fenugreek yield (Troginella foenum-graecum L.) and diosgenin content in the plant drug,” Rostl Vyroba 2001; 47 [Abstract].
Liu F et al., “An extract ofLangerstroemia speciosaL. has insulin-like glucose uptake-stimulatory and adipocyte differenctiation-inhibitory activities in 3T3-L1 cells,” Journal of Nutrition 2001; 131(9): 2242-7 [Abstract].
Breil et al., “Effect of 4-hydroxyisoleucine on insulin sensitivity in insulin resistant rats,” European Association for the Study of Diabetes, 37th Annual Meeting, Glasgow, United Kingdom, Sep. 9-13, 2001, Abstract: 300.
Andrich VS, “Sports Supplement Review. The Lowdown on Insulin Amplifiers and Glycemic Response Modifiers,” Muscle Media Article, Jan.-Feb. 2001.
van Loon LJC et al., “Maximizing postexercise muscle glycogen synthesis: carbohydrate supplementation and the application of amino acid or protein hydrolysate mixtures,” URL: http://www.acjn.org/cgi/content/abstract/72/1/106 (Accessed Mar. 26, 2002), American Journal of Clinical Nutrition, Jul. 2000; 72(1): 106-11.
van Loon LJC et al., “Plasma insulin reponses after ingestion of different amino acid or protein mixtures with carbohydrate,” URL: http://www.acjn.org/cgi/content/abstract/72/1/96 (Accessed Mar. 26, 2002), American Journal of Clinical Nutrition, Jul. 2000; 72(1): 96-105.
Kassem T, et al., “Two key chiral intermediates in a new 4-hydroxyisoleucine synthesis,” Acta Crystallographica 2000; C56: 1037-9.
Huang et al., “Determination of two flavone glycosides in the seeds of Trigonella foenum-graecum L. from various production locality,” Zhiwu Ziyuan Yu Huanjing Xuebao 2000; 9(4): 53-4. [Abstract].
Broca C, et al., “4-hydroxyisoleucine: Effects of synthetic and natural analogues on insulin secretion,” European Journal of Pharmacology 2000; 390: 339-345.
Blumenthal M (ed), “Fenugreek Seed,” Herbal Medicine: Expanded Commission E Monographs, American Botanical Council 2000.
Plesman J, “Fenugreek Stabilizes Blood Sugar Levels in Hypoglycemics and Diabetics,” Hypoglycemic Health Newsletter. 2000; 16(1): 9-12.
Broca C, et al., “4-hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties,” American Journal of Physiology Oct. 2001; 277(4 Pt 1): E617-23.
Muralidhara et al., “Acute and subchronic toxicity assessment of debitterized fenugreek powder in the mouse and rat,” Food and Chemical Toxicology 1999; 37(8): 831-8. [Abstract].
Genet et al., “Effects of vandate, insulin and fenugreek (Trigonella foenum greacum) on creatine kinase levels in tissues of diabetic rat,” Indian Journal of Experimental Biology Feb. 1999; 37(2): 200-2. [Abstract].
Raju et al., “Effect of antidiabetic compounds on glyoxalase I activity in experimental diabetic rat liver,” Indian Journal of Experimental Biology Feb. 1999; 37(2): 193-5. [Abstract].
Szentmihalyi et al., “Investigation of Troginella foenum-graecum L. Fabacea oil. Comparative evaluation of samples from supercritical and conventional extraction,” Olaj, Szappan, Kozmet 1999; 48(5): 204-6. [Abstract].
Panda et al., “Inhibition of triiodothyronine production by fenugreek seed extract in mice and rats,” Pharmacological Research Jan. 1999; 40(5): 405-9 [Abstract].
Ravikumar et al., “Effect of fenugreek seeds on blood lipid peroxidation and antioxidants in diabetic rats,” Phytotherapy Research May 1999; 13(3): 197-201. [Abstract].
Sowmya et al., “Hypocholesterolemic effect of germinated fenugreek seeds in human subjects,” Plant Foods for Human Nutrition 1999; 53(4): 359-65. [Abstract].
Sauvaire Y, et al., “4-hydroxyisoleucine: A novel amino acid potentiator of insulin secretion,” Diabetes 1998; 47: 206-10.
Puri D, “Therapeutic potentials of fenugreek,” Indian Journal of Physiology and Pharmacology Jul. 1998; 42(3): 423-4. [Abstract].
Taylor et al., “Analysis of steroidal sapogenins from Amber Fenugreek (Trigonella foenum-graecum) by capillary gas chromatography and combined gas chromatography/mass spectrometry,” Journal of Agricultural and Food Chemistry 1997; 45(3): 753-9. [Abstract].
Bordia et al., “Effect of ginger (Zingiber officinale Rosc.) And fenugreek (Trigonella foenumgraecum L.) On blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease,” Prostaglandins, Leukotrienes, and Essential Fatty Acids May 1997; 56(5): 379-84. [Abstract].
Wang et al., “Studies on chemical constituents of the stems and leaves of Trigonella foenum-graecum L,” Zhongguo Zhongyao Zazhi 1997; 22(8): 486-7. [Abstract].
Sauvaire et al., “Steroid saponins from fenugreek and some of their biological properties,” Advances in Experimental Medicine and Biology 1996; 405: 37-46. [Abstract].
Rao et al., “Short term nutritional
Hynson Richard B.
Lee Steve S.
Li Wu-Zhou
Zhang Ke-Qin
Zhou Jing Shi
Flood Michele
Pate & Pierce & Baird
TSI Health Sciences, Inc.
LandOfFree
Fenugreek seed bio-active compositions and methods for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fenugreek seed bio-active compositions and methods for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fenugreek seed bio-active compositions and methods for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3931981